Global Radiopharmaceuticals Market Analysis Report 2022: A $7.2 Billion Market by 2027 – Industry Trends, Share, Size, Growth, Opportunities and Forecasts –


DUBLIN–(BUSINESS WIRE)–The report “Radiopharmaceuticals Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027” has been added to from offer.

The global radiopharmaceuticals market reached a value of US$4.9 billion in 2021. Going forward, the market is expected to reach US$7.2 billion by 2027, growing at a CAGR of 6.62% in 2021-2027.

Keeping in mind the uncertainties of COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic on different end-use sectors. This information is included in the report as a major market contributor.

Radiopharmaceuticals Market Trends:

The increasing prevalence of cancerous diseases due to the aging population and unhealthy dietary habits represent the main factors contributing to the increasing use of radiopharmaceuticals worldwide. Apart from this, the growing number of diagnostic centers is also supporting the market.

Additionally, the growing number of oncologists suggesting disease-targeted cancer therapy, which uses drugs to target specific proteins and genes involved in cancer cell development, is positively influencing overall sales.

Additionally, the use of radiolabeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors, along with the increase in healthcare expenditure, is driving the growth of the market.

Other major factors that are expected to propel the market growth include the increasing use of radiopharmaceuticals by oncologists to track radioactivity throughout the body and determine the presence of cancer cells and the increasing shift to Positron Emission Tomography ( PET) and single photon emission computed tomography. (SPECT).

Answers to key questions in this report:

  • How has the global radiopharmaceutical market behaved so far and how will it behave in the years to come?

  • What has been the impact of COVID-19 on the global radiopharmaceuticals market?

  • What are the main regional markets?

  • What is the market breakdown by product type?

  • What is the market breakdown by application?

  • What is the market breakdown by end use?

  • What are the different stages of the industry value chain?

  • What are the key drivers and challenges in the industry?

  • What is the structure of the global radiopharmaceuticals market and who are the main players?

  • How competitive is the industry?

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of key players

  • Advanced Accelerator Applications (Novartis AG)

  • Bayer AG

  • Bracco SpA

  • Cardinal Health Inc.

  • Curium Pharma

  • General electricity company

  • IBA RadioPharma Solutions

  • Jubilant Pharma Limited

  • Lantheus Medical Imaging Inc

  • Nordion Inc. (Sotera Health)

  • NTP Radioisotopes SOC Ltd

  • PharmaLogic Holdings Corp.

  • Siemens AG

Key Market Segmentation:

Breakdown by product type:

  • Diagnostic nuclear medicine

  • Therapeutic nuclear medicine

Breakdown by application:

  • Oncology

  • Cardiology

  • Neurology

  • Endocrinology

  • Others

Breakdown by end use:

  • Hospitals and Clinics

  • Research institutes

  • Diagnostic centers

Breakdown by region:

North America

Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Others


  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Russia

  • Others

Latin America

  • Brazil

  • Mexico

  • Others

  • Middle East and Africa

For more information about this report visit

Source link

Comments are closed.